FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2067024114> ?p ?o ?g. }

• W2067024114 endingPage "595" @default.
• W2067024114 startingPage "588" @default.
• W2067024114 abstract "Inhibition of phosphodiesterase 4 (PDE4) represents an approach to anti-inflammatory therapy in chronic obstructive pulmonary disease (COPD). GSK256066 is a potent and selective inhaled PDE4 inhibitor. The aim of this study was to investigate the safety and tolerability of 28 days repeat inhaled dosing with GSK256066 in moderate COPD.This was a Phase IIa, multicenter, parallel-group, double-blind, three-arm, placebo-controlled, four-week, randomized study with two doses of GSK256066 (25 μg, 87.5 μg). The primary endpoint was safety and tolerability. Secondary endpoints included changes in inflammatory markers in induced sputum and blood, lung function (spirometry, body plethysmography, impulse oscillometry), and pharmacokinetics.104 patients were randomized and 94 patients completed the study. The incidence and intensity of treatment-related adverse events were similar between treatment groups. The most frequent adverse event was nasopharyngitis and there were no serious adverse events in patients receiving GSK256066. The overall incidence of gastrointestinal adverse events was low in all treatment groups. There were no statistically significant changes in inflammatory markers in induced sputum and blood following treatment with GSK256066. Analysis of sputum mRNA suggested engagement of pharmacology, based on increased expression of cAMP-dependent genes including amphiregulin and CREM in subjects receiving GSK256066. There was a trend for an increase in post-bronchodilator FEV1 for both doses of GSK256066; in addition, for the 87.5 μg group, there was a mean reduction in residual volume of 0.367 L (95% confidence interval: 0.112, 0.622 L) relative to placebo.Administration of inhaled GSK256066 was well-tolerated in patients with moderate COPD. Further studies would be required to confirm the favorable safety profile and to demonstrate clinical efficacy of this compound. (ClinicalTrials.gov identifier: NCT00549679)." @default.
• W2067024114 created "2016-06-24" @default.
• W2067024114 creator A5012242776 @default.
• W2067024114 creator A5041661080 @default.
• W2067024114 creator A5087999170 @default.
• W2067024114 date "2013-10-01" @default.
• W2067024114 modified "2023-09-30" @default.
• W2067024114 title "Safety and tolerability of the inhaled phosphodiesterase 4 inhibitor GSK256066 in moderate COPD" @default.
• W2067024114 cites W1966614349 @default.
• W2067024114 cites W1977722786 @default.
• W2067024114 cites W1994100994 @default.
• W2067024114 cites W1994127425 @default.
• W2067024114 cites W2016222031 @default.
• W2067024114 cites W2026549814 @default.
• W2067024114 cites W2035046153 @default.
• W2067024114 cites W2087968375 @default.
• W2067024114 cites W2088957014 @default.
• W2067024114 cites W2096189541 @default.
• W2067024114 cites W2096700673 @default.
• W2067024114 cites W2097243317 @default.
• W2067024114 cites W2097771640 @default.
• W2067024114 cites W2101175089 @default.
• W2067024114 cites W2125078269 @default.
• W2067024114 cites W2135702050 @default.
• W2067024114 cites W2141323574 @default.
• W2067024114 cites W2146965595 @default.
• W2067024114 cites W2154616892 @default.
• W2067024114 cites W2161713331 @default.
• W2067024114 cites W4237807778 @default.
• W2067024114 doi "https://doi.org/10.1016/j.pupt.2013.05.004" @default.
• W2067024114 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23701917" @default.
• W2067024114 hasPublicationYear "2013" @default.
• W2067024114 type Work @default.
• W2067024114 sameAs 2067024114 @default.
• W2067024114 citedByCount "43" @default.
• W2067024114 countsByYear W20670241142013 @default.
• W2067024114 countsByYear W20670241142014 @default.
• W2067024114 countsByYear W20670241142015 @default.
• W2067024114 countsByYear W20670241142016 @default.
• W2067024114 countsByYear W20670241142017 @default.
• W2067024114 countsByYear W20670241142018 @default.
• W2067024114 countsByYear W20670241142019 @default.
• W2067024114 countsByYear W20670241142020 @default.
• W2067024114 countsByYear W20670241142021 @default.
• W2067024114 countsByYear W20670241142022 @default.
• W2067024114 countsByYear W20670241142023 @default.
• W2067024114 crossrefType "journal-article" @default.
• W2067024114 hasAuthorship W2067024114A5012242776 @default.
• W2067024114 hasAuthorship W2067024114A5041661080 @default.
• W2067024114 hasAuthorship W2067024114A5087999170 @default.
• W2067024114 hasConcept C126322002 @default.
• W2067024114 hasConcept C142724271 @default.
• W2067024114 hasConcept C197934379 @default.
• W2067024114 hasConcept C204787440 @default.
• W2067024114 hasConcept C27081682 @default.
• W2067024114 hasConcept C2776042228 @default.
• W2067024114 hasConcept C2776301714 @default.
• W2067024114 hasConcept C2776719499 @default.
• W2067024114 hasConcept C2776780178 @default.
• W2067024114 hasConcept C2778375690 @default.
• W2067024114 hasConcept C2780333948 @default.
• W2067024114 hasConcept C2781018748 @default.
• W2067024114 hasConcept C2781069245 @default.
• W2067024114 hasConcept C42219234 @default.
• W2067024114 hasConcept C71924100 @default.
• W2067024114 hasConcept C90924648 @default.
• W2067024114 hasConcept C98274493 @default.
• W2067024114 hasConceptScore W2067024114C126322002 @default.
• W2067024114 hasConceptScore W2067024114C142724271 @default.
• W2067024114 hasConceptScore W2067024114C197934379 @default.
• W2067024114 hasConceptScore W2067024114C204787440 @default.
• W2067024114 hasConceptScore W2067024114C27081682 @default.
• W2067024114 hasConceptScore W2067024114C2776042228 @default.
• W2067024114 hasConceptScore W2067024114C2776301714 @default.
• W2067024114 hasConceptScore W2067024114C2776719499 @default.
• W2067024114 hasConceptScore W2067024114C2776780178 @default.
• W2067024114 hasConceptScore W2067024114C2778375690 @default.
• W2067024114 hasConceptScore W2067024114C2780333948 @default.
• W2067024114 hasConceptScore W2067024114C2781018748 @default.
• W2067024114 hasConceptScore W2067024114C2781069245 @default.
• W2067024114 hasConceptScore W2067024114C42219234 @default.
• W2067024114 hasConceptScore W2067024114C71924100 @default.
• W2067024114 hasConceptScore W2067024114C90924648 @default.
• W2067024114 hasConceptScore W2067024114C98274493 @default.
• W2067024114 hasFunder F4320307773 @default.
• W2067024114 hasIssue "5" @default.
• W2067024114 hasLocation W20670241141 @default.
• W2067024114 hasLocation W20670241142 @default.
• W2067024114 hasOpenAccess W2067024114 @default.
• W2067024114 hasPrimaryLocation W20670241141 @default.
• W2067024114 hasRelatedWork W2011384746 @default.
• W2067024114 hasRelatedWork W2015102355 @default.
• W2067024114 hasRelatedWork W2128740418 @default.
• W2067024114 hasRelatedWork W2149893136 @default.
• W2067024114 hasRelatedWork W2163046863 @default.
• W2067024114 hasRelatedWork W2551658844 @default.
• W2067024114 hasRelatedWork W2804985256 @default.
• W2067024114 hasRelatedWork W2807802647 @default.

• next